Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Katarzyna Domanska‐Czyz"'
Autor:
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, Katarzyna Domanska-Czyz, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Robert Konecki, Anna Borawska, Agnieszka Druzd-Sitek, Elzbieta Lampka, Wlodzimierz Osiadacz, Michal Osowiecki, Lidia Popławska, Monika Swierkowska, Lukasz Targonski, Joanna Tajer, Grazyna Lapinska, Malwina Smorczewska, Jan Walewski
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Primary mediastinal B-cell lymphoma (PMBL) is currently curable in 85–95% of patients. Treatment regimens frequently used include RCHOP ± radiotherapy, DAEPOCH-R, or occasionally more intensive protocols. Here we present results of treatm
Externí odkaz:
https://doaj.org/article/390d2e0cb00f467e8bbd36aeef3cedd8
Autor:
Beata Ostrowska, Katarzyna Domanska‐Czyz, Joanna Romejko‐Jarosinska, Michal Osowiecki, Lukasz Targonski, Lidia Poplawska, Robert Konecki, Martyna Kotarska, Marcin Szymanski, Anna Borawska, Monika Swierkowska, Anna Dabrowska‐Iwanicka, Agnieszka Druzd‐Sitek, Ewa Paszkiewicz‐Kozik, Ewa Mroz‐Zycinska, Joanna Tajer, Elzbieta Wojciechowska‐Lampka, Wlodzimierz Osiadacz, Grzegorz Rymkiewicz, Grazyna Lapinska, Marta Wojewodzka‐Mirocha, Wojciech Michalski, Jan Walewski
Publikováno v:
British Journal of Haematology. 201:663-672
Publikováno v:
Acta Haematologica Polonica. 52:29-37
Castleman disease is a very rare, lymphoproliferative disease, driven by dysregulation of the cytokine interleukin 6 (IL-6) and other proinflammatory cytokines with the development of symptoms of systemic inflammation, reactive proliferation of lymph
Autor:
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, Katarzyna Domanska-Czyz, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Robert Konecki, Anna Borawska, Agnieszka Druzd-Sitek, Elzbieta Lampka, Wlodzimierz Osiadacz, Michal Osowiecki, Lidia Popławska, Monika Swierkowska, Lukasz Targonski, Joanna Tajer, Grazyna Lapinska, Malwina Smorczewska, Jan Walewski
Publikováno v:
Scientific reports. 12(1)
Primary mediastinal B-cell lymphoma (PMBL) is currently curable in 85–95% of patients. Treatment regimens frequently used include RCHOP ± radiotherapy, DAEPOCH-R, or occasionally more intensive protocols. Here we present results of treatment of 12
Autor:
Agnieszka Szymczyk, Marek Hus, Waldemar Tomczak, Beata Ostrowska, Sebastian Rybski, Anna Dąbrowska-Iwanicka, Tomasz Wróbel, Magdalena Olszewska-Szopa, Jan Walewski, Joanna Romejko-Jarosinska, Katarzyna Domanska-Czyz
Publikováno v:
Leukemialymphoma. 62(12)
Castleman disease (CD) was first described in the 1954 by Benjamin Castleman as a rare nonmalignant lymphoproliferative disorder [1]. Multicentric CD (MCD) involves multiple regions of enlarged lym...
Autor:
Anita Borysiuk, Katarzyna Blachnio, Grzegorz Rymkiewicz, Wojciech Michalski, Zbigniew Bystydzienski, Sebastian Rybski, Jan Walewski, Beata Ostrowska, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, Magdalena Chechlinska
Publikováno v:
Cancers, Vol 13, Iss 1911, p 1911 (2021)
Cancers
Cancers
Simple Summary T-cell lymphoblastic lymphoma (T-LBL) is extremely rare and aggressive with no practical risk model defined. Considering the controversies over the prognostic value of T-LBL immunological subtypes, we re-evaluated 49 subsequent adult T
Autor:
Monika Prochorec-Sobieszek, Reiner Siebert, Magdalena Chechlinska, Grzegorz Rymkiewicz, Beata Grygalewicz, David Martín-García, Katarzyna Blachnio, Michalina Zajdel, Katarzyna Domanska-Czyz, Paweł Swoboda, Joanna Romejko-Jarosinska, Ferran Nadeu, Renata Woroniecka, Barbara Pienkowska-Grela, Jan Konrad Siwicki, Jan Walewski, Zbigniew Bystydzienski, Itziar Salaverria, Jolanta Rygier
Publikováno v:
Modern Pathology. 31:732-743
We previously described a subset of MYC translocation-negative aggressive B-cell lymphomas resembling Burkitt lymphoma, characterized by proximal gains and distal losses in chromosome 11. In the 2016 WHO classification, these MYC-negative lymphomas w
Autor:
Joanna Romejko-Jarosinska, Ewa Wasik-Szczepanek, Joanna Drozd-Sokołowska, Michal Osowiecki, Maja Twardosz, Anna Wisniewska, Beata Ostrowska, Agnieszka Druzd-Sitek, Anna Borawska, Kamila Kruczkowska-Taranowicz, Barbara Lewicka, Lukasz Targonski, Elżbieta Kalicińska, Malgorzata Debowska, Monika Swierkowska, Anna Dabrowska-Iwanicka, Iwona Hus, Marcin Szymanski, Ewa Lech-Marańda, Marta Morawska, Monika Palka, Monika Joks, Lidia Poplawska, Jan Walewski, Agata Tyczyńska, Monika Długosz-Danecka, Martyna Kotarska, Agnieszka Giza, Agnieszka Końska, Ewa Paszkiewicz-Kozik, Robert Konecki, Ryszard Swoboda, Katarzyna Domanska-Czyz
Publikováno v:
Blood. 138:4525-4525
Introduction: Obinutuzumab-based induction immunochemotherapy was demonstrated to improve the outcome of patients with follicular lymphoma (FL) comparing to the regimens with rituximab in GALLIUM study (NCT01332968). The infusion related reactions (I
Autor:
Agnieszka Druzd-Sitek, Anna Dabrowska-Iwanicka, Anna Borawska, Katarzyna Domanska-Czyz, Beata Ostrowska, Jan Walewski, Joanna Romejko-Jarosinska, Robert Konecki, Monika Swierkowska, Wlodzimierz Osiadacz, Elzbieta Wojciechowska-Lampka, Ewa Paszkiewicz-Kozik, Lukasz Targonski, Joanna Tajer, Lidia Poplawska, Martyna Kotarska, Marcin Szymanski
Publikováno v:
Journal of Clinical Oncology. 38:e20034-e20034
e20034 Background: Plasmablastic lymphoma (PBL) is a rare CD20-negative lymphoma with an aggressive clinical course and short median survival ranging from 9 to 32 months. It is often associated with HIV infection but it also affects immunocompetent p
Autor:
Agnieszka Druzd-Sitek, M. Mordak-Domagała, B. Kuniega, Joanna Romejko-Jarosinska, A. Lange, Anna Borawska, Jacek Najda, T. Szpila, Ewa Paszkiewicz-Kozik, Wanda Knopinska-Posluszny, Agata Malenda, Jan Walewski, Wojciech Michalski, K. Warzocha, Beata Ostrowska, Ł. Targoński, M. Świerkowska, Lidia Poplawska, Michał Szymański, Grzegorz Rymkiewicz, M. Chełstowska, Michal Osowiecki, Jan Maciej Zaucha, R. Konecki, Anna Dąbrowska-Iwanicka, M. Kotarska, Katarzyna Domanska-Czyz, Andrzej Pluta, Sebastian Giebel, M. Taszner
Publikováno v:
Hematological Oncology. 37:436-437